Angiotensin converting enzyme inhibitors in heart failure: how good are they?
作者信息
Townend J N, Littler W A
机构信息
Department of Cardiovascular Medicine, University of Birmingham, Queen Elizabeth Hospital, Edgbaston, Birmingham.
出版信息
Br Heart J. 1993 May;69(5):373-5. doi: 10.1136/hrt.69.5.373.
Abstract
摘要
相似文献
1
Angiotensin converting enzyme inhibitors in heart failure: how good are they?心力衰竭中的血管紧张素转换酶抑制剂：它们的效果如何？
Br Heart J. 1993 May;69(5):373-5. doi: 10.1136/hrt.69.5.373.
2
Recent developments in the pharmacotherapy of cardiac failure.
Med J Aust. 1992 Sep 7;157(5):292-4. doi: 10.5694/j.1326-5377.1992.tb137175.x.
3
Angiotensin converting enzymes inhibitors in heart failure.心力衰竭中的血管紧张素转换酶抑制剂
Ir Med J. 1993 Mar;86(2):46-7.
4
[Comparison of candesartan, enalapril and their combination in congestive heart failure].坎地沙坦、依那普利及其联合用药治疗充血性心力衰竭的比较
Ital Heart J Suppl. 2000 Mar;1(3):429-30.
5
6
[Angiotensin-converting enzyme inhibitors in heart failure].[血管紧张素转换酶抑制剂治疗心力衰竭]
Tidsskr Nor Laegeforen. 1987 Sep 10;107(25):2112-6.
7
[Treatment with angiotensin conversion enzyme inhibitors in heart failure].
Rev Med Chir Soc Med Nat Iasi. 2002 Jan-Mar;106(1):122-7.
8
[Therapy of chronic heart failure with angiotensin-converting enzyme inhibitors].[血管紧张素转换酶抑制剂治疗慢性心力衰竭]
Dtsch Med Wochenschr. 1988 Oct 28;113(43):1684-9. doi: 10.1055/s-2008-1067874.
9
Angiotensin converting enzyme inhibitors and magnesium conservation in patients with congestive cardiac failure.血管紧张素转换酶抑制剂与充血性心力衰竭患者的镁保留
Br Heart J. 1991 Jul;66(1):19-21. doi: 10.1136/hrt.66.1.19.
10
Digoxin and angiotensin converting enzyme inhibitors in chronic heart failure.慢性心力衰竭中的地高辛与血管紧张素转换酶抑制剂
Can J Cardiol. 1990 Aug;6 Suppl C:14C-17C.
引用本文的文献
1
Hibernating myocardium in post-ischaemic heart failure: pathophysiology, identification and revascularisation.缺血性心力衰竭中的冬眠心肌：病理生理学、识别与血运重建
Ann R Coll Surg Engl. 2000 Jul;82(4):236-42.
2
Coronary revascularisation for postischaemic heart failure: how myocardial viability affects survival.缺血性心力衰竭的冠状动脉血运重建：心肌存活性如何影响生存率。
Heart. 1999 Dec;82(6):684-8. doi: 10.1136/hrt.82.6.684.
3
The effects of an angiotensin-converting inhibitor (enalapril) on patients with mild cardiac failure--evaluating cardiac function based on the relationship between daily walking pace and heart rate.血管紧张素转换酶抑制剂（依那普利）对轻度心力衰竭患者的影响——基于日常步行速度与心率之间的关系评估心脏功能
Clin Cardiol. 1998 Dec;21(12):893-8. doi: 10.1002/clc.4960211207.
4
When to start an ACE inhibitor and in whom.何时开始使用血管紧张素转换酶抑制剂以及适用于哪些人。
Cardiovasc Drugs Ther. 1994 Feb;8(1):111-4. doi: 10.1007/BF00877097.
5
ACE for whom? Implications for clinical practice of post-infarct trials.血管紧张素转换酶抑制剂（ACEI）适用于谁？心肌梗死后试验对临床实践的启示。
Br Heart J. 1995 May;73(5):470-4. doi: 10.1136/hrt.73.5.470.
6
Coronary artery disease, valvular heart disease, bradycardia, and heart failure.冠状动脉疾病、心脏瓣膜病、心动过缓和心力衰竭。
Postgrad Med J. 1995 Jun;71(836):346-53. doi: 10.1136/pgmj.71.836.346.
本文引用的文献
1
Hydralazine in the long-term treatment of chronic heart failure: lack of difference from placebo.肼屈嗪用于慢性心力衰竭的长期治疗：与安慰剂无差异。
Am Heart J. 1982 Sep;104(3):587-94. doi: 10.1016/0002-8703(82)90231-9.
2
Captopril in heart failure. A double blind controlled trial.卡托普利治疗心力衰竭。一项双盲对照试验。
Br Heart J. 1984 Nov;52(5):530-5. doi: 10.1136/hrt.52.5.530.
3
Controlled trial of captopril in chronic heart failure: a rest and exercise hemodynamic study.卡托普利治疗慢性心力衰竭的对照试验：一项休息及运动时的血流动力学研究。
Circulation. 1983 Apr;67(4):807-16. doi: 10.1161/01.cir.67.4.807.
4
Enalapril in patients with chronic heart failure: a placebo-controlled, randomized, double-blind study.依那普利治疗慢性心力衰竭患者：一项安慰剂对照、随机、双盲研究。
Circulation. 1984 Aug;70(2):271-8. doi: 10.1161/01.cir.70.2.271.
5
Prenatal diagnosis of congenital rubella.
Lancet. 1984 Jul 7;2(8393):1-3. doi: 10.1016/s0140-6736(84)91993-7.
6
Decreased lymphocyte beta-adrenergic-receptor density in patients with heart failure and tolerance to the beta-adrenergic agonist pirbuterol.心力衰竭患者淋巴细胞β-肾上腺素能受体密度降低及对β-肾上腺素能激动剂吡布特罗的耐受性
N Engl J Med. 1981 Jul 23;305(4):185-90. doi: 10.1056/NEJM198107233050402.
7
Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy.
Am J Cardiol. 1987 Mar 1;59(6):634-8. doi: 10.1016/0002-9149(87)91183-0.
8
Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.血管扩张剂疗法对慢性充血性心力衰竭死亡率的影响。退伍军人管理局合作研究的结果。
N Engl J Med. 1986 Jun 12;314(24):1547-52. doi: 10.1056/NEJM198606123142404.
9
Controlled trial of enalapril in congestive cardiac failure.依那普利治疗充血性心力衰竭的对照试验。
Br Heart J. 1985 Oct;54(4):405-14. doi: 10.1136/hrt.54.4.405.
10
Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state.依那普利对心力衰竭的影响：关于对运动能力、肾功能、激素及代谢状态影响的双盲研究。
Br Heart J. 1985 Sep;54(3):305-12. doi: 10.1136/hrt.54.3.305.
Zotero 插件